Literature DB >> 11115489

Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy.

G W Waterer, R G Wunderink, C B Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115489     DOI: 10.1378/chest.118.6.1839-a

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  14 in total

Review 1.  Role of beta-lactam agents in the treatment of community-acquired pneumonia.

Authors:  J Garau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

2.  Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.

Authors:  Ricardo Dias; Deolinda Louro; Manuela Caniça
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Macrolide resistance in Streptococcus pneumoniae: Fallacy or fact?

Authors:  Jm Conly; Bl Johnston
Journal:  Can J Infect Dis       Date:  2002-01

Review 4.  Azithromycin extended release: a review of its use in the treatment of acute bacterial sinusitis and community-acquired pneumonia in the US.

Authors:  Tracy Swainston Harrison; Susan J Keam
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Microbiological Features of Upper Respiratory Tract Infections in Bulgarian Children for the Period 1998-2014.

Authors:  Raina Tzvetanova Gergova; Guergana Petrova; Stefan Gergov; Petko Minchev; Ivan Mitov; Tanya Strateva
Journal:  Balkan Med J       Date:  2016-11-01       Impact factor: 2.021

Review 6.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  What Is the Clinical Impact of Macrolide Resistance?

Authors:  John R. Lonks
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

8.  Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.

Authors:  Keith A Rodvold; Larry H Danziger; Mark H Gotfried
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

9.  Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 250 invasive Streptococcus pneumoniae isolates from France.

Authors:  J W Decousser; P Pina; F Picot; P Y Allouch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-27       Impact factor: 3.267

Review 10.  International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.

Authors:  Thomas M File; James S Tan
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.